x
Black Bar Banner 1
x

Alert!  New Secured Wallets are installed! new Blog system with AI  power and auto blog curation coming soon  Alert! 

A+ A−
Ads by Markethive - View All
Blogs
The Blog Feed
Write a New Blog Post
Search Blog Status
Most Viewed
Most Recent
Most Shared
Alphabetical
Blog Main Menu
Markethive Blog (default)
All Blogs
My Blog Posts
Friends' Blogs
Blog Categories
All
Advertising
Blockchain & Cryptocurrency
Business Development
Diet & Weight Loss
Environmental
Health and Wellness
History and Culture
Home and Garden
Marketing
Mentoring & Training
Money & Finance
Other
Political
Prayer & Religion
Programming & Technical
Real Estate
Search Engine Optimization
Social Media
Spirituality
Sports & Recreation
Transport
Travel & Events
Website Design
Blogging Tools & Assets
My Blog Info
Members Subscribed to You
Blogs You Are Subscribed To
Website Widget
Wordpress Plugin
Subscribe for Greater Services
Subscribe to one of many subscriptions, each one includes the previous ones.. Unlock powerful tools, advance features, to build a powerful reach.

Altered Microbiome in Cystic Fibrosis

Posted by Bobby Brown on May 02, 2021 - 11:24pm


Cystic fibrosis (CF) causes severe damage to the lungs, digestive system and other organs in the body. The disease is inherited when both parents carry the recessive gene.

A defective gene makes mucus, sweat and digestive juices thick and sticky instead of thin and slippery; tubes and ducts, especially in the lungs and pancreas become blocked.

Microbiota Impacted

The gut microbiota in CF are disrupted by frequent antibiotics as well as the genetic mutation which results in transmembrane conductance regulator (CFTR) dysfunction. To explore that premise, researchers in Ireland recently looked at the effect of CF on the microbiome. “The altered gut microbiota in adults with cystic fibrosis” appears in BMC Microbiology online in March 2017.

Their study utilized participants from Cork Adult Cystic Fibrosis Centre, Cork University Hospital. The gut microbiota of 43 people with CF compared to 69 without CF was assessed by 454-pyrosequencing of the 16S rRNA gene. The impact of clinical parameters, including antibiotic therapy, on the results was evaluated.

Results

CF compared to non-CF controls:

  • reduced microbial diversity
  • increased Firmicutes
  • reduced Bacteroidetes

Other findings:

  • CF individuals presenting with severe lung dysfunction had reduced gut microbiota diversity relative to those presenting with mild or moderate dysfunction.
  • There was no significant difference in the gut microbiota diversity or bacterial populations in people with CF receiving proton pump inhibitors (PPI) therapy, compared to those not receiving PPIs.
  • No significant differences occurred between those carrying C. difficile and those without C. difficile.

Probiotics

Good news. Some studies show probiotic use in CF results in decreased pulmonary exacerbationsreduced hospital admissions and benefits in the gut microbiota. Indeed, a recent review of the literature concluded that “probiotics may improve respiratory and gastrointestinal outcomes in a stable CF clinic population with no reported evidence of harm.”

Unfortunately, due to sparse evidence, many questions arise when deciding strain, species or dose.

Yet that lack shouldn’t prevent people with CF from  maintaining or restoring a healthy microbiota in CF. Cultured and fermented foods along with prebiotics (lots of fruits and vegetables) offer safe dabbling while supplement specifics evolve. Dietary advice in CF should move beyond the “any calorie is welcome” to making  “every  calorie contribute to health.”